Kompleksy [M(CQ)₂] (M = Ni, Pd i Pt, CQ = kliochinol) - analogi karboplatyny

• Autorzy: Vranec P. , Potočňák I.

Warianty tytułu

EN

[M(CQ)₂] complexes (M = Ni, Pd and Pt, CQ = clioquinol) - analogues of carboplatin

• Języki publikacji: PL

Abstrakty

PL

Otrzymano związki koordynacyjne [M(CQ)₂] (M = Ni, Pd lub Pt, CQ = 5-chloro-7-jodo-chinolin-8-ol, kliochinol) i zbadano za pomocą spektroskopii w podczerwieni i analizy termicznej. Na podstawie rentgenografii strukturalnej stwierdzono, że kompleksy [Ni(CQ)₂] i [Pd(CQ)₂] są molekularnymi związkami koordynacyjnymi z atomami centralnymi, wokół których skoordynowane są w układzie płaskim kwadratowym atomy azotu i tlenu dwóch dwukleszczowych cząsteczek kliochinolu w konfiguracji trans. Zbadano również oddziaływania niewiążące w tych dwu kompleksach. Struktury krystalicznej [Pt(CQ)₂] nie ustalono, ale na podstawie dyfraktogramów proszkowych stwierdzono, że wszystkie trzy badane kompleksy są izostrukturalne. Oceniono aktywność biologiczną tych związków.

EN

[M(CQ)₂] (M = Ni, Pd or Pt, CQ = 5-chloro-7-iodo-quinolin-8-ol, clioquinol) coordination compounds were prepared and characterized by infrared spectroscopy and thermal analysis. X-ray structure analysis revealed that the [Ni(CQ)₂] and [Pd(CQ)₂] complexes are molecular coordination compounds with central atoms square-planarly coordinated by nitrogen and oxygen atoms of two trans-arranged bidentate molecules of clioquinol. Nonbonding interactions in these two complexes were also investigated. The crystal structure of [Pt(CQ)₂] was not solved but according to powder diffractograms of all three prepared complexes, all complexes are isostructural. Biological activities of these compounds were evaluated.

Słowa kluczowe

PL

pallad; platyna; kliochinol; struktura

EN

palladium; platinum; clioquinol; structure

• Wydawca: Stowarzyszenie Inżynierów i Techników Przemysłu Chemicznego, ZW CHEMPRESS-SITPChem
• Czasopismo: Chemik
• Rocznik: 2012
• Tom: Vol. 66, nr 6
• Strony: 575--584
• Opis fizyczny: Bibliogr. 27 poz., 4 rys., 4 tabl.

Twórcy

autor

Vranec P.

autor

Potočňák I.

• Katedra Chemii Nieorganicznej, Instytut Chemii, Uniwersytet im. P. J. Szafarzika w Koszycach, Słowacja

Bibliografia

• 1. Andrews RA., Howell, S. B.: Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 1990, 2, 35.
• 2. Harrap K.R.: Initiatives with platinum- and quinazoline-based antitumor molecules. Cancer. Res. 1995, 55, 2761.
• 3. Bloemink M.J., Reedijk J.: Cisplatin and derived anticancer drugs: Mechanism and current status of DNA binding. Met. Ions Biol. Syst. 1996, 32, 641.
• 4. Lebwohl D., Canetta R.: Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur. J. of Cancer 1998,34, 1522.
• 5. Goddard R, Valenti M., Kelland L.R.: The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts. Anticancer Res. 1994, 14, 1065.
• 6. MissetJ.L., Bleiberg H. Sutherland, W. Bekradda M., Cvitkovic E.: Oxaliplatin clinical activity: a review. Crit. Rev. Oncol.- Hematol. 2000, 35, 75.
• 7. Regland B., Lehmann W, Abedini l„ Blennow K., Jonsson M., Karlsson I., Sjogren M., Wallin A., Xilinas M., Gottfries C.G.: Treatment of Alzheimer's disease with clioquinol, Dement. Geriatr. Cogn. Disord. 2001, 12,408.
• 8. Kaur D., Yantiri F„ Rajagopalan S., Kumar J., Mo J.Q.: Boonplueang R„ Viswa-nath V, Jacobs, R., Yang L, Beal M.F., DiMonte D., Volitaskis I., Ellerby L., Cherny R. A., Bush A.I., Andersen J.K.: Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 2003, 37, 899.
• 9. Ding W. Q., Liu B., Vaught J.L., Yamauchi H., Lind S.E.: Anticancer activity of the antibiotic clioquinol. Cancer. Res. 2005, 65, 3389.
• 10. Potocnak I., Vranec R: Low-dimensional compounds containing bioactive ligands. I: Crystal structure, spectroscopic, and thermal properties of the first row transition metal coordination compounds with clioquinol. Monats. Chem. 2011, DOI: 10.1007/s00706cp 11 cp678ci).
• 11. Keller R.N.: Inorganic Syntheses, vol. II, New York - London, 1946, 247.
• 12. Oxford Diffraction, Crysalis CCD and Crysalis RED 2004, Oxford, UK, Oxford Diffraction Ltd-
• 13. Sheldrick G.M.: SHELXS97 and SHELXL97 1997, Gottingen, Germany, University of Gottingen.
• 14. Brandenburg K: DIAMOND (Release 2. Ie) 2000, Bonn, Germany, Crystal Impact GbR.
• 15. Rodríguez-Carvajal J.: Recent Developments of the Program FULLPROF. in Commission on Powder Diffraction (lUCr), Newsletter 2001, 26, 12.
• 16. Horak M., Papousek D.: Infracervena spektra a struktura molekul 1976, Academia, Praha.
• 17. Zajcev B.E., Andronova N.A., Djumaev K.M., Smirnov L.D.: Infrared spectra and structures of 3-oxyquinoline, 4-oxyisoquinoline and their derivatives. Khim. Geterotsikl. Soed. 1971, 1535.
• 18. Leon Palomino M.I., Zajcev B.E., Gashev S.B., Nikitin S.V., Smirnov L.D., Kovaichukova O.V: Synthesis, electronic structure and absorption spectra of [1,2-a] pyrimidinium 9-oxypyrido derivatives. Khim. Geterotsikl. Soed. 1991, 1381.
• 19. Rospenk M„ Leroux N., Zeegers-Huyskens T.: Assignment of the Vibrations in the Near-Infrared Spectra of Phenol-OH(OD) Derivatives and Application to the Phenol-Pyrazine Complex. J. Mol. Spectrosc. 1997, 183,245.
• 20. Wagner C.C., Calvo S., Torre M.H., Baran E.J.: Vibrational spectra of clioquinol and its Cu(II)complex. J. Raman Spectrosc. 2007, 38, 373.
• 21. Arjunan V, Mohanb S., Ravindranc R, Mythilid C.V: Vibrational spectroscopic investigations, ab initio and DFT studies on 7-bromo-5-chloro-8-hydroxyquinoline, Spectrochim. Acta Part A 2009, 72, 783.
• 22. González-Baró A.C., Baran E.j.: Oxovanadium(IV) Complexes of Halogenated Oxines. Monatsh. Chem. 1997, 128, 323.
• 23. Vaira M.D., Bazzicalupi C, Orioli R, Messori L., Bruni B., Zatta R: Clioquinol, a Drug for Alzheimer's Disease Specifically Interfering with Brain Metal Metabolism: Structural Characterization of Its Zinc(II) and Copper(II) Complexes. Inorg. Chem. 2004, 43, 3795.
• 24. Garcia-Granda S., Gomez-Beltran F.: Structure ofbis(5-chloro-8-quinolinolato-N,0)bis(pyridine)nickel(II)-pyridine dihydrate, Acta Crystallogr. Sect. C: Cryst. Struct. Commun. 1986, 42, 33.
• 25. Garcia-Granda S., Beurskens RT, Behm H.J.J., Gomez-Beltran F: Structure of bis(5,7-dichloro-8-quinolinolato-N,0)bis(pyridine)nickel(II). Acta Crystallogr. Sect. C: Cryst. Struct. Commun. 1987, 43, 39.
• 26. Kappaun S., Eder S., Sax S., Saf R., Mereiter K, List E.J.W.: Slugovc, Ch., WPLEDs prepared from main-chain fluorene-iridium(III) polymers. J. Mater. Chem. 2006, 16,4389.
• 27. Gniewek A., Ziolkowski J.J., Lis T.: Trans-lodo-'(p-iodo-'phen-'yl)bis-'(tri-phenyl-'phosphine)palladium(II). Acta Cryst. Sect. E: Struct. Rep. Online 2006,62, ml428.